12.Jun.202312.Jun.202326.May.202312.May.202326.Apr.202320.Oct.202212.Oct.202205.Oct.202223.Jun.2022東京証券取引所グロース市場への上場に関するお知らせ
20.May.2022東京証券取引所グロース市場への上場承認に関するお知らせ
13.Oct.202120.Sep.202119.Sep.202126.Aug.202125.May.2021World’s first discovery of the molecular mechanisms of violet light for myopia: Violet light suppresses myopia progression via the non-visual photoreceptor, OPN5.
21.May.2021Major milestone in exploratory clinical trial for a medical device: Confirmation of the suppressive effect of violet light on myopia progression
01.Feb.2021Case Report of Axial Length Shortening in a High Myopic Child After Wearing Violet Light-Transmitting Eyeglasses
23.Dec.2020A major step in the development of a medical device for the suppression of myopia progression Safety was confirmed in the exploratory clinical trial
07.Dec.2020研究員募集のお知らせ
26.May.2020Our comments on the press release for the “Kubota Glasses” Developed by Kubota Pharmaceutical Holdings Co., Ltd.
12.May.2020We will join 2020 BIO International Convention Digital.
